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General Practice — Clinical Practice
and weakness.2-4 It is one of the main causes
of undiagnosed muscle pain in adults.2,3
Such pain resolves rapidly with adequate
doses of vitamin D.3-5
Risk factors for vitam  D defici ncy
include darker skin pigmentation, urban









AuT  prevalence of vitamin D defi-ncy among Aboriginal people instralia is unknown. One of the
possible sequelae of vitamin D deficiency,
muscle pain, appears to have a higher preva-
lence in Aboriginal people.
A deficiency of vitamin D can cause osteo-
porosis,1 rickets in children, muscle pain
sons, and intestinal malabsorption or a diet
deficient in vitamin D.1,6-10
Refugees from Africa and the Middle East
are known to have a high risk of rickets and
muscle pain caused by vitamin D defi-
ciency.2-4,8-11 There is also research showing
a deficiency in asymptomatic patients, both
those at high risk as well as those with no
obvious risk factors.12 This is important for
the infants of women who are deficient in
vitamin D during their pregnancy, as their
children will also be deficient in vitamin
D,13,14 and hence at increased risk of both
short- and long-term sequelae.8,13
A study of a rural Aboriginal community
found that 95% of the population had
chronic non-specific musculoskeletal pain,
compared with 30% in the general popula-
tion.15 Traditional Aboriginal people spent
much of their day outdoors, but most now
have an urban lifestyle.16 They are less likely
to spend enough hours in the sun1 or have a
diet rich in vitamin D.1,6
After noting a high prevalence of muscu-
lar pain among patients at our health service
(Nunkuwarrin Yunti, an Aboriginal Com-
munity Controlled Health Service, at Eliza-
beth Downs in the northern suburbs of
Adelaide), we conducted a case–control
study to determine if muscle pain was asso-
ciated with low vitamin D levels.
METHODS
Discussions about the study’s relevance with
Elder Aboriginal Women in the community,
and with the staff and Chief Executive Officer
of Nunkuwarrin Yunti acknowledged its
importance to individuals, families and the
community. Ethics approval was obtained
from the University of Adelaide and the Abori-
ginal Health Research Ethics Committee.
Results from Indigenous patients seen in
our clinical practice before the study showed
a serum vitamin D (25-hydroxyvitamin D)
range of 35–55 nmol/L (standard deviation,
5 nmol/L). Anticipating a difference between
cases (with muscle pain) and controls (with-
uscle pain) of 10 nmol/L, we calculated
a sample of six cases and six controls
d be required, assuming a power of 0.8
 significance level of 0.05.
ta were collected from eight patients in
group in October and November 2005,
e end of the Australian winter. Blood
samples were collected from patients aged
18 years and older with muscle pain and
from a sex- and age-matched control group
without muscle pain. People with renal fail-
ure or who had recently taken vitamin D
supplements were excluded. All patients
had what would be classed as medium skin
pigmentation.17
The blood samples were sent to the local
pathology service, where 25-hydroxyvit-
amin D was measured. Serum levels were
tabulated and analysed using SPSS version
13.0 (SPSS Inc, Chicago, Ill, USA).
RESULTS
Our results are summarised in the Box. All
patients with muscle pain had a vitamin D
level below the normal value of 50nmol/L.1,18
The mean vitamin D level was 40.88 nmol/L
(SD, 3.52 nmol/L) for patients with muscle
pain, and 58.25 nmol/L (SD, 15.90 nmol/L)
for controls.
Data were normally distributed and equal
variances could not be assumed. A t test
showed a mean difference between cases
and controls of −17.38 nmol/L (P = 0.017).
DISCUSSION
The eight Aboriginal patients with muscle
pain had lower vitamin D levels than those
without muscle pain. Vitamin D deficiency
was not observed in asymptomatic patients
except for one with mild deficiency. Despite
being at a lower risk of osteoporosis,19
Aboriginal people may have an increased
risk of muscular symptoms of vitamin D
deficiency. We did not assess intercurrent
illness, severity of symptoms, skin pigmen-
tation, diet, time spent outdoors and success
of treatment, and this limitation may affect
the generalisability of our findings.
We found that muscle pain is an indicator
of vitamin D deficiency in urban Aboriginal
patients. General practitioners are well
placed to screen those at high risk and may
be able to improve the lifestyle and level of
function of many previously undiagnosed
patients with chronic muscle pain by having
a high index of suspicion for vitamin D
deficiency.
As more research reveals the sequelae of
vitamin D deficiency, its importance to gen-
eral health is likely to increase. A larger
Sex, age, vitamin D level and vitamin D class* for patients with muscle pain and 
controls with no muscle pain














F 50 37 3 F 50 50 4
F 38 40 3 F 35 70 4
F 39 38 3 F 40 78 4
F 72 37 3 F 55 28 3
F 19 41 3 F 20 50 4
F 48 46 3 F 47 56 4
F 62 45 3 F 55 63 4
M 53 43 3 M 53 71 4
* Vitamin D class: class 4,  50 nmol/L, normal; class 3, 26–49 nmol/L, mild deficiency; class 2, 12.5–25 nmol/L, 
moderate deficiency; class 1, < 12.5 nmol/L, severe deficiency.1,18 ◆76 MJA • Volume 185 Number 2 • 17 July 2006
GENERAL PR ACTICE  — CLINICAL PRACTICEstudy looking at the prevalence of muscle
pain in the urban Aboriginal population, its
effect on lifestyle, how that pain relates to
vitamin D deficiency, and whether pain is
reduced with treatment would clarify some
of the issues. The potential for better quality
of life resulting from successful treatment of
muscle symptoms caused by vitamin D defi-
ciency makes the clarification of this associ-
ation a priority for Aboriginal health.
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